Dry reagent-based polymerase chain reaction compared with other laboratory methods available for the diagnosis of Buruli ulcer disease

Clinical Infectious Diseases

Volumn 45, Issue 1, 2007, Pages 68-75

  Siegmund, Vera ^a,b   Adjei, Ohene ^c   Nitschke, Jörg ^b   Thompson, William ^d   Klutse, Erasmus ^e   Herbinger, Karl Heinz ^a   Thompson, Ruth ^c   Van Vloten, Felicitas ^b   Racz, Paul ^b   Fleischer, Bernhard ^b   Loescher, Thomas ^a   Bretzel, Gisela ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c KUMASI CENTRE FOR COLLABORATIVE RESEARCH IN TROPICAL MEDICINE   (Ghana)

^d Agogo Presbyterian Hospital   (Ghana)

^e Dunkwa Governmental Hospital   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BURULI ULCER; CONTROLLED STUDY; DIAGNOSTIC TEST; GHANA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STANDARDIZATION;

DIAGNOSIS, DIFFERENTIAL; GHANA; HUMANS; MICROBIOLOGICAL TECHNIQUES; MYCOBACTERIUM INFECTIONS, ATYPICAL; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SKIN DISEASES, BACTERIAL;

EID: 34250827766     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/518604     Document Type: Article

References (16)

1. Sizaire V, Nackers F, Comte E, Portaels F. Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect Dis 2006; 6: 288-96.
2. van der Werf TS, Stienstra Y, Johnson RC, et al. Mycobacterium ulcerans disease. Bull World Health Organ 2005; 83:785-91.
3. World Health Organization. Buruli ulcer. Management of Mycobacterium ulcerans disease. Geneva: World Health Organization, 2001.
4. Amofah G, Bonsu F, Tetteh C, et al. Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis 2002; 8:167-70.
5. Debacker M, Aguiar J, Steunou C, et al. Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, southern Benin, 1997-2001. Emerg Infect Dis 2004; 10:1391-8.
6. King CH, Ashford DA, Dobos K, et al. Mycobacterium ulcerans infection and Buruli ulcer disease: emergence of a public health dilemma. Washington, DC: ASM Press, 2001.
7. Siegmund V, Adjei O, Racz P, et al. Dry-reagent-based PCR as a novel tool for laboratory confirmation of clinically diagnosed Mycobacterium ulcerans - associated disease in areas in the tropics where M. ulcerans is endemic. J Clin Microbiol 2005; 43:271-6.
8. Whitney EAS, Phelan M, Raghunathan PL, et al. Latent class analysis (LCA) evaluation of four diagnostic tests for Buruli ulcer disease. In: 5th World Health Organization Advisory Group Meeting on Buruli Ulcer. Geneva: World Health Organization, 2002.
9. World Health Organization. Buruli ulcer. Diagnosis of Mycobacterium ulcerans disease. Geneva: World Health Organization, 2001.
10. Guimaraes-Peres A, Portaels F, de Rijk P, et al. Comparison of two PCRs for detection of Mycobacterium ulcerans. J Clin Microbiol 1999; 37:206-8.
11. N'Guessan K, Kouassi Y, Bouzid S, et al. Value and limits of microscopy of exudates in Mycobacterium ulcerans cutaneous infection in Cote d'Ivoire [in French]. Bull Soc Pathol Exot 2001; 94:9-10.
12. Stinear T, Ross BC, Davies JK, et al. Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR. J Clin Microbiol 1999; 37:1018-23.
13. Bretzel G, Siegmund V, Nitschke J, et al. External quality assurance for the laboratory diagnosis of Buruli ulcer disease in Ghana. Trop Med Int Health 2006; 11:1688-93.
14. Bretzel G, Siegmund V, Nitschke J, et al. A stepwise approach to the laboratory diagnosis of Buruli ulcer disease. Trop Med Int Health 2007; 12:89-96.
15. Guarner J, Bartlett J, Whitney EA, et al. Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis 2003; 9:651-6.
16. Mve-Obiang A, Lee RE, Umstot ES, et al. A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin. Infect Immun 2005; 73:3307-12.